About Us > Sarah Mougalian, MD

Sarah Mougalian, MD

Highlights

  • Assistant professor at the Yale School of Medicine
featured_paragraph

Sarah Mougalian, MD is an assistant professor of medicine at the Yale School of Medicine in Connecticut. Dr. Mougalian treats people with breast cancer and works with the school's COPPER (Cancer Outcomes, Public Policy, and Effectiveness Research) Center. There she studies chemotherapy regimens in breast cancer treatment and how they are used in clinical practice.

contributions_carousel

Contributions

FAC

10/07/19 | BY: Sarah Mougalian

FAC (Fluorouracil, Adriamycin, and Cytoxan) is a chemotherapy regimen sometimes given for localized breast cancers with a relatively high risk for recurrence.

Read More
 | 4 Min. Read |

Epirubicin

08/16/19 | BY: Sarah Mougalian

Epirubicin (Ellence) is a type of anthracycline chemotherapy. It is made from the Streptomyces peucetius bacteria.

Read More
 | 5 Min. Read

Paclitaxel

08/09/19 | BY: Sarah Mougalian

Paclitaxel (Taxol) is a type of taxane chemotherapy. Paclitaxel is made from the bark of the Pacific yew tree. It is used to treat breast cancer as well as many other types of cancer.

Read More
 | 6 Min. Read |